Table 1 Demographics and clinical characteristics of children with MHHs.
Variables | ≤4 Cutaneous IHs | ≥5 Cutaneous IHs | Total | P-values |
|---|---|---|---|---|
n = 15 | n = 27 | n = 42 | ||
Age at diagnosis (month)*,† | 2.0 (1.5–3.0) | 2.1 (1.5–3.0) | 2.1 (1.5–3.0) | 0.65 |
Gender‡ | 1.00 | |||
Male | 4 (26.7) | 7 (25.9) | 11 (26.2) | |
Female | 11 (73.3) | 20 (74.1) | 31 (73.8) | |
Gestational age‡ | 0.49 | |||
Term born | 3 (20.0) | 9 (33.3) | 12 (28.6) | |
Born prematurely | 12 (80.0) | 18 (66.7) | 30 (71.4) | |
Hepatomegaly‡ | 0.72 | |||
Yes | 3 (20.0) | 8 (29.6) | 11 (26.2) | |
No | 12 (80.0) | 19 (70.4) | 31 (73.8) | |
Congestive heart failure‡ | 1.00 | |||
Yes | 1 (6.7) | 2 (7.4) | 3 (7.1) | |
No | 14 (93.3) | 25 (92.6) | 39 (92.9) | |
Hypothyroidism‡ | 0.86 | |||
Yes | 0 (0) | 2 (7.4) | 2 (4.8) | |
No | 12 (80.0) | 19 (70.4) | 31 (73.8) | |
Unknown | 3 (20.0) | 6 (22.2) | 9 (21.4) | |
Number of MHH lesions‡ | 0.43 | |||
2–4 | 8 (53.3) | 9 (33.3) | 17 (40.5) | |
5–9 | 4 (26.7) | 8 (29.6) | 12 (28.6) | |
≥10 | 3 (20.0) | 10 (37.0) | 13 (30.9) | |
Liver arteriovenous shunt‡ | 0.69 | |||
Yes | 2 (13.3) | 6 (22.2) | 8 (19.0) | |
No | 13 (86.7) | 21 (77.8) | 34 (81.0) | |
Treatment for MHH‡ | 0.09 | |||
Yes | 3 (20.0) | 11 (40.7) | 14 (33.3) | |
No | 12 (80.0) | 16 (59.3) | 28 (66.7) | |
Mortality‡ | 0.53 | |||
Yes | 0 (0) | 2 (7.4) | 2 (4.8) | |
No | 15 (100) | 25 (92.6) | 40 (95.2) | |
Duration of follow-up (month)† | 44.0 (30.0–70.0) | 48.0 (36–72.0) | 48.0 (36.0–70.1) | 0.50 |
